Cambridge Investment Research Advisors, Inc.
Position in SGMOQ — Sangamo Therapeutics, Inc
CIK 1419186
FAIRFIELD, IA
Position in SGMOQ
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$9,504
-$4,699 QoQ
Shares Held
38,017
+12.4% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in SGMOQ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $60,632,692 across 72 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,946 | $10,901,236 | |
| 2 | EXEL |
Exelixis, Inc.
|
82,212 | $4,473,154 | |
| 3 | NKTR |
Nektar Therapeutics
|
56,186 | $3,922,344 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
35,157 | $3,056,901 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
15,839 | $2,966,327 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,591 | $2,862,672 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
46,210 | $2,520,293 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
30,727 | $2,288,546 |
All Filings in SGMOQ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,504 | 38,017 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $14,203 | 33,817 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $23,309 | 34,790 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $17,166 | 31,790 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $17,021 | 25,790 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $26,305 | 25,790 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $22,437 | 25,790 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $9,176 | 25,490 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $16,944 | 25,290 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $16,509 | 30,574 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $18,512 | 30,854 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $40,110 | 30,854 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $54,303 | 30,854 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $96,881 | 30,854 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $151,468 | 30,912 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $127,975 | 30,912 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $167,688 | 28,862 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $217,215 | 28,962 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $265,831 | 29,504 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $353,988 | 29,573 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $436,119 | 34,806 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $543,321 | 34,806 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $282,980 | 29,945 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $269,203 | 30,045 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $191,386 | 30,045 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||